Reduced risk of colorectal cancer recurrence after surgery
Top line: With the improvement of colorectal cancer Survival and recurrence rates after (CRC) surgery have also decreased significantly over the past 20 years. methodology: Advances over the past 20 years have improved survival rates for colorectal cancer, but it is unclear whether these advances have reduced the risk of recurrence after surgery. To find […]
SGLT2 inhibitors in T2DM are associated with reduced gastrointestinal cancer risk
Vancouver, Canada — The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancer in patients with: type 2 diabetes New evidence emerges in comparison with dipeptidyl peptidase IV (DPP4) inhibitors. SGLT2 inhibitors were found to be better than DPP4 inhibitors in reducing the risk of colorectal, liver, […]
Eubiotic effects of rifaximin are associated with reduced abdominal pain in symptomatic uncomplicated diverticular disease: results of an observational cohort study | BMC Gastroenterology
To our knowledge, this study is the first to evaluate the long-term (i.e., 6 months) effects of rifaximin on the gut microbiota of SUDD patients. Here we show that rifaximin significantly reduced the severity of abdominal pain, which is consistent with previous studies. [9,10,11,12]. Treatment with rifaximin over 6 months was not associated with significant […]